HE4 is also used to evaluate the treatment effect of ovarian cancer.270,272 In addition, HE4 is also overexpressed in other non-gynecologic malignancies, including NSCLC, pancreatic cancer, and transitional cell carcinoma.273. This evidence concerns the gene WFDC2 and ovarian carcinoma.